Data / Drug companies / Carbidopa and levodopa
Carbidopa and levodopa: 41 companies and 118 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Carbidopa and levodopa is listed in the FDA National Drug Code Directory by 41 companies, with 118 products in commercial distribution. 99 of the products (83.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release; capsule, extended release, and the newest product started marketing on July 13, 2026.
The request: Get every company that lists carbidopa and levodopa in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 41
- Products
- 118
- Generic (ANDA) products
- 99 (83.9%)
- Application numbers
- 22
- Routes
- Oral, Enteral
- Brand names
- Carbidopa-levodopa, Rytary, Crexont, Sinemet, Duopa
- openFDA record search
- api.fda.gov
Companies that list carbidopa and levodopa
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amneal Pharmaceuticals LLC | 8 | capsule, extended release | New drug applications (NDA) | August 9, 2024 |
| A-S Medication Solutions | 7 | tablet | Generic drugs (ANDA) | November 28, 2022 |
| Advagen Pharma Ltd | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | June 4, 2024 |
| Coupler LLC | 5 | tablet | Generic drugs (ANDA) | July 13, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | May 1, 2024 |
| Remedyrepack Inc. | 5 | capsule, extended release; tablet | Authorized generics (NDA) | April 24, 2026 |
| ScieGen Pharmaceuticals, Inc. | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | October 5, 2021 |
| Sun Pharmaceutical Industries, Inc. | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | August 12, 2021 |
| Zydus Pharmaceuticals USA Inc. | 4 | capsule, extended release | Authorized generics (NDA) | October 20, 2025 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | November 28, 2022 |
| AvKARE | 3 | tablet | Generic drugs (ANDA) | February 21, 2024 |
| Camber Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | May 27, 2025 |
| Dr. Reddy's Laboratories Inc. | 3 | tablet | Generic drugs (ANDA) | May 1, 2024 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | September 30, 2021 |
| Rising Pharma Holdings, Inc. | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | January 8, 2025 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | December 15, 2014 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet | Generic drugs (ANDA) | December 15, 2023 |
| TruPharma, LLC | 3 | tablet | Generic drugs (ANDA) | September 21, 2022 |
| Westminster Pharmaceuticals, LLC | 3 | tablet | Generic drugs (ANDA) | September 30, 2021 |
| XLCare Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | January 19, 2026 |
| Accord Healthcare Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | June 13, 2013 |
| Alembic Pharmaceuticals Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | June 6, 2019 |
| Alembic Pharmaceuticals Limited | 2 | tablet, extended release | Generic drugs (ANDA) | June 6, 2019 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | March 16, 2024 |
| Amneal Pharmaceuticals NY LLC | 2 | tablet, extended release | Generic drugs (ANDA) | December 21, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | March 15, 2022 |
| Bryant Ranch Prepack | 2 | tablet, extended release | Generic drugs (ANDA) | October 5, 2021 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | November 28, 2022 |
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | October 10, 2025 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | April 28, 2025 |
| Mylan Institutional Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | February 1, 2002 |
| Mylan Pharmaceuticals Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | April 26, 2000 |
| Organon LLC | 2 | tablet | New drug applications (NDA) | February 28, 2025 |
| Radha Pharmaceuticals, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | April 25, 2025 |
| Safecor Health, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | March 13, 2026 |
| AbbVie Inc. | 1 | suspension | New drug applications (NDA) | January 15, 2015 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | July 28, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | January 19, 2026 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | June 23, 2026 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | September 21, 2022 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | October 28, 2008 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 69 | 58.5% |
| Tablet, extended release | 26 | 22% |
| Capsule, extended release | 16 | 13.6% |
| Tablet, orally disintegrating | 6 | 5.1% |
| Suspension | 1 | 0.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 99 | 83.9% |
| New drug applications (NDA) | 11 | 9.3% |
| Authorized generics (NDA) | 8 | 6.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Aromatic Amino Acid | 118 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.